Overview

Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis

Status:
Completed
Trial end date:
1999-08-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the efficacy and safety of gammalinolenic acid in the treatment of childhood arthritis.
Phase:
N/A
Details
Lead Sponsor:
FDA Office of Orphan Products Development
Collaborator:
University of Massachusetts, Worcester
Treatments:
Efamol
Evening primrose oil